SCAI 2025: 4 Trials Under Discussion
• Clinical Outcomes of Stented vs. Non-Stented CTO Patients
• Orthopedic Risks to Cardiac Catheterization Operators wearing traditional lead protection versus using novel lead-less solutions: Insights from the Prospective ERGO-CATH Study
• Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population
• Etiology, Management, and Outcomes in SCAI Stage B Cardiogenic Shock
• Clinical Outcomes of Stented vs. Non-Stented CTO Patients
• Orthopedic Risks to Cardiac Catheterization Operators wearing traditional lead protection versus using novel lead-less solutions: Insights from the Prospective ERGO-CATH Study
• Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population
• Etiology, Management, and Outcomes in SCAI Stage B Cardiogenic Shock
© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Cath Lab Digest or HMP Global, their employees, and affiliates.
Join Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, and Drs Morton Kern and Arnold Seto, in a Society of Cardiovascular Angiography and Interventions (SCAI) 2025 Annual Meeting discussion that highlights four trials across the interventional cardiology spectrum, from CTO stenting vs non-stenting clinical outcomes to operator safety and system-level practice patterns.
Topics include the comparative outcomes of stented versus non-stented chronic total occlusion (CTO) patients; the orthopedic risks faced by cath lab operators wearing traditional lead protection versus novel lead-free systems in the prospective ERGO-CATH study; procedural volume trends and outcomes of percutaneous coronary intervention (PCI) in ambulatory surgery centers within the Medicare population; and the etiology, management, and outcomes in patients with SCAI Stage B cardiogenic shock.
Choose "Chapters" in the video below to jump to a particular trial discussion, or listen to the discussion in its entirety:
Trial #1: Clinical Outcomes of CTO Patients: 00:24
Trial #2: ERGO-Cath Study: 5:16
Trial #3: PCI in ASCs: 17:40
Trial #4: SCAI Stage B Cardiogenic Shock: 27:57
Read more about each trial:
- Clinical Outcomes of Stented vs. Non-Stented CTO Patients
- Orthopedic Risks to Cardiac Catheterization Operators wearing traditional lead protection versus using novel lead-less solutions: Insights from the Prospective ERGO-CATH Study
- Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population
- Etiology, Management, and Outcomes in SCAI Stage B Cardiogenic Shock
